The group currently has no business and evaluates various strategic alternatives, including acquisitions of new operating businesses and technologies as well as potential merger opportunities. The principal activity is to develop and commercialize novel drugs based on biotechnological research.
Executive Information
Name
Title
Email
Gareb Shamus
Chmn., CEO
N/A
Jay Larkin
CEO
N/A
Joel Ehrlich
Chief Marketing Officer, Pres. - Sales
N/A
Kurt Otto
Founder - IFL Corp
N/A
Joe Favorito
Sr. VP - Communications, Marketing, Public Relations, New York, IFL Corp
